These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 12687273
21. Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Mayer A, Höckel M, Vaupel P. Clin Cancer Res; 2005 Oct 15; 11(20):7220-5. PubMed ID: 16243791 [Abstract] [Full Text] [Related]
22. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M. Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1197-207. PubMed ID: 15752902 [Abstract] [Full Text] [Related]
23. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA. Breast Cancer Res Treat; 2003 Sep 15; 81(2):137-47. PubMed ID: 14572156 [Abstract] [Full Text] [Related]
24. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Dubois L, Douma K, Supuran CT, Chiu RK, van Zandvoort MA, Pastoreková S, Scozzafava A, Wouters BG, Lambin P. Radiother Oncol; 2007 Jun 15; 83(3):367-73. PubMed ID: 17502120 [Abstract] [Full Text] [Related]
25. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, Pastorek J, Cox GJ, Ratcliffe P, Harris AL. Cancer Res; 2001 Jul 01; 61(13):5262-7. PubMed ID: 11431368 [Abstract] [Full Text] [Related]
26. Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts. Ditte Z, Ditte P, Labudova M, Simko V, Iuliano F, Zatovicova M, Csaderova L, Pastorekova S, Pastorek J. BMC Cancer; 2014 May 22; 14():358. PubMed ID: 24886661 [Abstract] [Full Text] [Related]
27. Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing. Čepa A, Ráliš J, Marešová L, Kleinová M, Seifert D, Sieglová I, Král V, Polášek M, Paurová M, Lázníček M, Lebeda O. Appl Radiat Isot; 2019 Jan 22; 143():87-97. PubMed ID: 30391716 [Abstract] [Full Text] [Related]
28. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography. Pan J, Lau J, Mesak F, Hundal N, Pourghiasian M, Liu Z, Bénard F, Dedhar S, Supuran CT, Lin KS. J Enzyme Inhib Med Chem; 2014 Apr 22; 29(2):249-55. PubMed ID: 23463940 [Abstract] [Full Text] [Related]
29. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus. Lim HY, Ahn M, Chung HC, Gardner TA, Kao C, Lee SJ, Kim SJ. Cancer Gene Ther; 2004 Aug 22; 11(8):532-8. PubMed ID: 15167900 [Abstract] [Full Text] [Related]
30. New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples. Stravinskiene D, Imbrasaite A, Petrikaite V, Matulis D, Matuliene J, Zvirbliene A. Biomolecules; 2019 Jul 25; 9(8):. PubMed ID: 31349673 [Abstract] [Full Text] [Related]
31. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia. Bao B, Groves K, Zhang J, Handy E, Kennedy P, Cuneo G, Supuran CT, Yared W, Rajopadhye M, Peterson JD. PLoS One; 2012 Jul 25; 7(11):e50860. PubMed ID: 23226406 [Abstract] [Full Text] [Related]
32. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines. Hunakova L, Bodo J, Chovancova J, Sulikova G, Pastorekova S, Sedlak J. Neoplasma; 2007 Jul 25; 54(6):541-8. PubMed ID: 17949239 [Abstract] [Full Text] [Related]
33. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides. Lau J, Zhang Z, Jenni S, Kuo HT, Liu Z, Vullo D, Supuran CT, Lin KS, Bénard F. Mol Pharm; 2016 Mar 07; 13(3):1137-46. PubMed ID: 26866675 [Abstract] [Full Text] [Related]
34. The use of CA-IX as a diagnostic method for oral leukoplakia. Pérez-Sayáns M, Suárez-Peñaranda JM, Torres-López M, Supuran CT, Gándara-Vila P, Gayoso-Diz P, Barros-Angueira F, Gallas-Torreira M, García-García A. Biotech Histochem; 2015 Feb 07; 90(2):124-31. PubMed ID: 25297562 [Abstract] [Full Text] [Related]
35. G250: a carbonic anhydrase IX monoclonal antibody. Lam JS, Pantuck AJ, Belldegrun AS, Figlin RA. Curr Oncol Rep; 2005 Mar 07; 7(2):109-15. PubMed ID: 15717944 [Abstract] [Full Text] [Related]
36. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use. Pastorek J, Pastorekova S. Semin Cancer Biol; 2015 Apr 07; 31():52-64. PubMed ID: 25117006 [Abstract] [Full Text] [Related]
37. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Zatovicova M, Jelenska L, Hulikova A, Csaderova L, Ditte Z, Ditte P, Goliasova T, Pastorek J, Pastorekova S. Curr Pharm Des; 2010 Apr 07; 16(29):3255-63. PubMed ID: 20819068 [Abstract] [Full Text] [Related]
38. Expression of carbonic anhydrase IX in human pancreatic cancer. Juhász M, Chen J, Lendeckel U, Kellner U, Kasper HU, Tulassay Z, Pastorekova S, Malfertheiner P, Ebert MP. Aliment Pharmacol Ther; 2003 Oct 15; 18(8):837-46. PubMed ID: 14535878 [Abstract] [Full Text] [Related]
39. Screening of a novel peptide targeting the proteoglycan-like region of human carbonic anhydrase IX. Rana S, Nissen F, Lindner T, Altmann A, Mier W, Debus J, Haberkorn U, Askoxylakis V. Mol Imaging; 2013 Oct 15; 12(8):. PubMed ID: 24447616 [Abstract] [Full Text] [Related]
40. Effect of polarity and differentiation on antibody localization in multicellular tumour spheroid and xenograft models and its potential importance for in vivo immunotargeting. Pervez S, Kirkland SC, Epenetos AA, Mooi WJ, Evans DJ, Krausz T. Int J Cancer; 1989 Nov 15; 44(5):940-7. PubMed ID: 2583872 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]